Center for Immunotherapy Research

Medicine & Life Sciences

1. Myeloid-Derived Suppressor Cells 100%
2. Genetic Therapy 87%
3. Neoplasms 77%
4. Adenoviridae 73%
5. Thymidine Kinase 73%
6. Ganciclovir 58%
7. Interleukin-12 46%
8. T-Lymphocytes 46%
9. Simplexvirus 42%
10. Genes 40%
11. Neoplasm Metastasis 30%
12. Liver 29%
13. Myeloid Cells 27%
14. Therapeutics 26%
15. Oncogenes 26%
16. Immunity 25%
17. Animals 23%
18. Colon 21%
19. 4-1BB Ligand 21%
20. Regulatory T-Lymphocytes 20%
21. Sunitinib 20%
22. Cytokines 19%
23. Injections 18%
24. Suicide 18%
25. Prostatic Neoplasms 18%
26. Interleukin-4 18%
27. Macrophages 18%
28. Tumor Microenvironment 18%
29. Graft vs Host Disease 17%
30. Cell Line 17%
31. Natural Killer Cells 16%
32. Growth 16%
33. Carcinoma 16%
34. Apoptosis 16%
35. Dendritic Cells 15%
36. Interleukin-2 15%
37. Triple Negative Breast Neoplasms 15%
38. Immunotherapy 14%
39. Radiosurgery 13%
40. Hepatitis B virus 13%
41. Breast Neoplasms 13%
42. Experimental Melanomas 12%
43. Th17 Cells 12%
44. Adenocarcinoma 12%
45. Cancer Vaccines 11%
46. Immune Tolerance 11%
47. Monocytes 11%
48. Viruses 11%
49. Cell Differentiation 11%
50. Gene Expression 10%
51. Interleukin-4 Receptors 10%
52. Leukocytes 10%
53. Melanoma 10%
54. In Vitro Techniques 10%
55. Carcinogenesis 10%
56. Pancreatic Neoplasms 9%
57. Maintenance 9%
58. Sigmodontinae 9%
59. Granulocyte-Macrophage Colony-Stimulating Factor 9%
60. Survival 9%
61. Immunoglobulins 9%
62. Immune System 9%
63. Hepatitis B Antigens 8%
64. Image-Guided Radiotherapy 8%
65. Transplantation Tolerance 8%
66. Lymphoma 8%
67. Leukemia 8%
68. Cell Proliferation 8%
69. Tumor Burden 8%
70. Antibodies 8%
71. Nude Mice 8%
72. Rous sarcoma virus 8%
73. Viral Antigens 8%
74. Head and Neck Neoplasms 7%
75. Antigen-Presenting Cells 7%
76. 2-ethyl-8-(4-fluorophenyl)-6-methyl-3,4-dihydro-2H-(2,7)naphthyridin-1-one 7%
77. Clinical Trials, Phase I 7%
78. Hepatocellular Carcinoma 7%
79. Ligands 7%
80. Oncogene Addiction 7%
81. Tyrosine 7%
82. Immunomodulation 7%
83. Bystander Effect 7%
84. Cell Transplantation 7%
85. Neoplasm Genes 7%
86. Clinical Trials 7%
87. Sympathetic Nervous System 6%
88. Interleukin-10 6%
89. Nitric Oxide Synthase Type II 6%
90. Transgenic Mice 6%
91. Brain Neoplasms 6%
92. beta-naphthylsulfonyl-(d-Pip)-Ada-Abu-DFEEIPEEYLQ-OH-AcOH 6%
93. Endoplasmic Reticulum 6%
94. Hematopoietic Stem Cells 6%
95. Glioma 6%
96. thiosalicylic acid 6%
97. Genetic Recombination 6%
98. Urinary Bladder Neoplasms 5%
99. Phenotype 5%
100. Fluorouracil 5%